Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplanted into the heart for patients with severe heart failure. Target diseases include dilated cardiomyopathy, old myocardial infarction, and dilated-phase hypertrophic cardiomyopathy.